<SEC-DOCUMENT>0001628280-24-038196.txt : 20240822
<SEC-HEADER>0001628280-24-038196.hdr.sgml : 20240822
<ACCEPTANCE-DATETIME>20240822150058
ACCESSION NUMBER:		0001628280-24-038196
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20240819
FILED AS OF DATE:		20240822
DATE AS OF CHANGE:		20240822

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Johnson Paul Harold
		CENTRAL INDEX KEY:			0002034858
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-27446
		FILM NUMBER:		241231649

	MAIL ADDRESS:	
		STREET 1:		3515 LYMAN BLVD.
		CITY:			CHASKA
		STATE:			MN
		ZIP:			55318

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIFECORE BIOMEDICAL, INC. \DE\
		CENTRAL INDEX KEY:			0001005286
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				943025618
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0526

	BUSINESS ADDRESS:	
		STREET 1:		3515 LYMAN BOULEVARD
		CITY:			CHASKA
		STATE:			MN
		ZIP:			55318
		BUSINESS PHONE:		9523684300

	MAIL ADDRESS:	
		STREET 1:		3515 LYMAN BOULEVARD
		CITY:			CHASKA
		STATE:			MN
		ZIP:			55318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LANDEC CORP \CA\
		DATE OF NAME CHANGE:	19951222
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wk-form4_1724353252.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2024-08-19</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001005286</issuerCik>
        <issuerName>LIFECORE BIOMEDICAL, INC. \DE\</issuerName>
        <issuerTradingSymbol>LFCR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0002034858</rptOwnerCik>
            <rptOwnerName>Johnson Paul Harold</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O LIFECORE BIOMEDICAL, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>3515 LYMAN BLVD.</rptOwnerStreet2>
            <rptOwnerCity>CHASKA</rptOwnerCity>
            <rptOwnerState>MN</rptOwnerState>
            <rptOwnerZipCode>55318</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>0</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2024-08-19</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>24554</value>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>24554</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable></derivativeTable>

    <footnotes>
        <footnote id="F1">The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.</footnote>
        <footnote id="F2">Vests on earlier of July 8, 2025 or the date of the annual meeting of stockholders of the Company first held in calendar year 2025 (provided such date is no less than 50 weeks from July 8, 2024).</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>Rebecca J Hilt, Attorney-In-Fact for Paul Harold Johnson</signatureName>
        <signatureDate>2024-08-22</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
